Studies Point Way to Precision Therapies for Common Genetic Disorders

News   Feb 10, 2017 | Original story from Princeton University, Engineering School

 
Studies Point Way to Precision Therapies for Common Genetic Disorders

The researchers include: (from left) Trudi Schüpbach, the Henry Fairfield Osborn Professor of Biology; Rebecca Burdine, associate professor of molecular biology; Stanislav Shvartsman, Professor of Chemical and Biological Engineering and the Lewis Sigler Institute for Integrative Genomics; and Yogesh Goyal and Granton Jindal, graduate students in chemical and biological engineering.

 
 
 

RELATED ARTICLES

Extra-Resistant Wheat is Created From New Gene Combination

News

A new combination of different strains of resistant wheat may help farmers avoid a common fungal disease.

READ MORE

Protein That Helps Keep Breast Cancer Dormant Identified

News

A protein kinase that stops breast cancer cells growing and spreading has been outlined in new research.

READ MORE

Combination Chemotherapy Could Significantly Improve Deadly Brain Tumor Treatment

News

A team led by Massachusetts General Hospital (MGH) investigators has found that adding the chemotherapy drug hydroxyurea to the current chemotherapy protocol for glioblastoma significantly increased survival in animal models.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE